Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis

Gene Therapy

Volumn 17, Issue 10, 2010, Pages 1225-1233

  Wang, C R ^a   Shiau, A L ^a   Chen, S Y ^a   Cheng, Z S ^a   Li, Y T ^a   Lee, C H ^a   Yo, Y T ^a   Lo, C W ^a   Lin, Y S ^a   Juan, H Y ^a   Chen, Y L ^a   Wu, C L ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

angiogenesis; collagen induced arthritis; galectin 1; galectin 3; rheumatoid arthritis; T cell death

Indexed keywords

GALECTIN 1; GALECTIN 3; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LUCIFERASE; SHORT HAIRPIN RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTHRITIS; ARTICLE; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LYMPH NODE CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSGENE; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; GALECTIN 1; GALECTIN 3; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRA-ARTICULAR; LENTIVIRUS; RATS; RNA, SMALL INTERFERING; TRANSFECTION;

LENTIVIRUS; RATTUS;

EID: 77957979421     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.78     Document Type: Article

References (44)

1. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-1874.
2. Chang DM. Rheumatoid arthritis. In: Liu HW (ed). Taiwan Rheumatology Textbook. Rheumatology Society of ROC: Taipei, 2003 pp 175-188.
3. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-361.
4. Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov 2007; 6: 75-92.
5. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146: 857-868.
6. Jou IM, Shiau AL, Chen SY, Wang CR, Shieh DB, Tsai CS et al. Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. Arthritis Rheum 2005; 52: 339-344.
7. Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum 2005; 52: 1319-1324.
8. Shiau AL, Chen SY, Chang MY, Su CH, Chung SY, Yo YT et al. Prothymosin a lacking the nuclear localization signal as an effective gene therapeutic strategy in collagen-induced arthritis. J Immunol 2007; 178: 4688-4694.
9. Wang CR, Shiau AL, Chen SY, Lin LL, Tai MH, Shieh GS et al. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer. Arthritis Rheum 2008; 58: 1650-1656.
10. Rabinovich GA, Toscano MA. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009; 9: 338-352.
11. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirtm A, Klinzing S et al. Galectin-3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2788-2795.
12. Harjacek M, Diaz-Cano S, Miguel MD, Wolfe H, Maldonado CA, Rabinovich GA. Expression of galectin-1 and-3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J Rheumatol 2001; 28: 1914-1922.
13. Neidhart M, Zaucke F, von Knoch R, Jungel A, Michel BA, Gay RE et al. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric. Ann Rheum Dis 2005; 64: 419-424.
14. Rubinstein N, IIarregui JM, Toscano MA, Rabinovich GA. The role of galectin in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 2004; 64: 1-12.
15. IIarregui JM, Bianco GA, Toscano MA, Rabinovich GA. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis 2005; 64: 96-103.
16. Stowell SR, Qian Y, Karmakar S, Koyama NS, Dias-Baruffi M, Leffler H et al. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 2008; 180: 3091-4102.
17. Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum 2009; 60: 1604-1614.
18. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999; 190: 385-397.
19. Shou J, Bull CM, Li L, Qian HR, Wei T, Luo S et al. Identification of blood biomarkers of the rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 2006; 8: R28.
20. Mease PJ, Hobbs K, Chalmers A, El-Gabalawy H, Bookman A, Keystone E et al. Local delivery of a recombinant adenoasso-ciated vector containing a tumour necrosis factor a antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Ann Rheum Dis 2009; 68: 1247-1254.
21. Gouze E, Pawliuk R, Pilapil C, Gouze JN, Fleet C, Palmer GD et al. In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 2002; 5: 397-404.
22. Delgado M, Toscano MG, Benabdellah K, Cobo M, O'Valle F, Gonzalez-Rey E et al. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Arthritis Rheum 2008; 58: 1026-1037.
23. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29-41.
24. Dumic J, Dabelic S, Flogel M. Galectin-3: an open ended story. Biochim Biophys Acta 2006; 1760: 616-635.
25. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002; 1572: 263-273.
26. Hsu DK, Yang RY, Liu FT. Galectins in apoptosis. Methods Enzymol 2006; 417: 256-273.
27. Matarrese P, Tinari N, Semeraro MI, Natoli C, Iacobelli S, Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondria homeostasis. FEBS Lett 2000; 473: 311-315.
28. Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu FT. Human T lymphotropic virus-1 infection of human T lymphocytes induces expression of the b-galactose-binding lectin, galectin-3. Am J Pathol 1996; 148: 1661-1670.
29. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003; 112: 389-397.
30. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666-669.
31. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
32. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510-516.
33. Gouze E, Pawliuk R, Gouzw JN, Pilapil C, Fleet C, Palmer GD et al. Lentiviral-mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation. Mol Ther 2003; 7: 460-466.
34. Gouze E, Gouze JN, Palmer GD, Pilapil C, Evans CH, Ghivizzani SC. Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases. Mol Ther 2007; 15: 1114-1120.
35. Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008; 10: e17.
36. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156: 899-909.
37. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 2006; 103: 15975-15980.
38. Nangia-Makker P, Raz T, Tait L, Hogan V, Fridman R, Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res 2007; 67: 11760-11768.
39. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004; 172: 4618-4623.
40. Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 2008; 27: 3746-3753.
41. Salmon P, Trono D. Production and titration of lentiviral vectors. In: Current Protocols in Human Genetics. John Wiley & Sons: New York, 2007 Unit 12.10.1-12.10.24.
42. Morgan K, Clague RB, Shaw MJ, Holt PJ. Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis 1980; 39: 285-290.
43. Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum 2007; 56: 544-554.
44. Woods JM, Katschke KJ, Volin MV, Ruth JH, Woodruff DC, Amin MA et al. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 2001; 166: 1214-1222.